The content on this site is intended for healthcare professionals only
Ovarian ablation for premenopausal breast cancer patients
PARP inhibitors for metastatic breast cancer
Why we need more well trained biobankers
Encouraging enrolment in clinical trials and ethics
Where have we got to with cancer treatment?
Breast cancer care in low-middle income settings
Discovering therapeutics for cancer
Steps for patients who do not receive complete response after neoadjuvant therapy
Endometrial biopsy interpretation: Difficulties and challenges
BRCA testing in breast and ovarian cancer
Advances in breast cancer treatment over the last 20 years
HIPEC: Treatment for peritoneal and ovarian carcinoma
An overview of recent metastatic HER2 breast cancer trials
Modern mammography-guided breast interventions
The added value of contrast-enhanced spectral mammography for the assessment of symptomatic breast cancer patients
Chemotherapy in patients with luminal breast cancer and an intermediate risk recurrence score
Dual HER2 blockade in patients with HER2-positive breast cancer after pCR
Preoperative management of operable cT3 cN1 luminal breast cancer: Upfront neoadjuvant chemotherapy
Radiation oncology in Saudi Arabia
Updated recommendations for the management of advanced ovarian cancer
Managing gynaecological cancers during pregnancy
Uterine sarcomas: The role of radiotherapy
Managing and treating vulvar cancer
Biobanking of patient-derived cancer models for applied research and clinical application
Triple-positive breast cancer: Systemic management strategies
Immunotherapy for cervical and endometrial cancer: Latest data and future perspectives
Immunotherapy for NSCLC: Recent advances and future directions
Breast cancer in Morocco
Updates in the ABC5 guidelines for the treatment of luminal metastatic breast cancer
Current controversies in breast cancer treatment
What is cancer and how can we prevent it?
Highlights from BGICC 2020
Combining chemotherapy and hormone therapy for the treatment of luminal metastatic breast cancer
Ductal carcinoma in situ, are we over-treating it?
An overview of breast cancer in Malaysia
Intraoperative radiotherapy for breast cancer
MRI morphology of malignant breast cancer lesions
Benign lesions that mimic breast cancer
Breast cancer in the young
Latest FIGO staging for cervical carcinoma
PARP inhibitors and immunotherapy in ovarian cancer: From research to practice
The age of genomic profiling
Identifying BRCA mutations for breast and ovarian cancer
AORTIC working with BGICS for better cancer care in Africa
